Knoll Capital Management as of June 30, 2015
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 19 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 81.0 | $251M | 2.2M | 114.20 | |
| Synthetic Biologics | 3.1 | $9.7M | 3.4M | 2.85 | |
| Ampio Pharmaceuticals | 2.6 | $8.1M | 3.4M | 2.39 | |
| Alcobra SHS | 2.4 | $7.3M | 1.1M | 6.54 | |
| Abeona Therapeutics | 2.2 | $6.9M | 1.4M | 5.06 | |
| Advaxis Com New | 1.8 | $5.6M | 275k | 20.33 | |
| Corbus Pharmaceuticals Hldgs | 1.7 | $5.4M | 1.8M | 3.08 | |
| Newlink Genetics Corporation | 1.5 | $4.5M | 102k | 44.27 | |
| Bio Blast Pharma SHS | 0.8 | $2.3M | 338k | 6.89 | |
| Keryx Biopharmaceuticals | 0.6 | $2.0M | 200k | 9.98 | |
| Caladrius Biosciences | 0.6 | $1.9M | 1.0M | 1.87 | |
| Advaxis W Exp 07/15/201 | 0.6 | $1.7M | 113k | 15.55 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $1.1M | 136k | 7.76 | |
| Lion Biotechnologies | 0.3 | $890k | 97k | 9.17 | |
| Galmed Pharmaceuticals SHS | 0.2 | $654k | 65k | 10.06 | |
| OHR Pharmaceutical Com New | 0.2 | $515k | 205k | 2.51 | |
| Evoke Pharma | 0.1 | $291k | 56k | 5.23 | |
| Zosano Pharma | 0.0 | $145k | 20k | 7.25 | |
| Aptose Biosciences Com New | 0.0 | $102k | 20k | 5.10 |
